Abstract | OBJECTIVE: To investigate the clinical features of COVID-19 cases in Suzhou China. Biomarkers were screened out of hematological parameters for risk stratification. METHOD: Confirmed COVID-19 adult patients in Suzhou were included. The patient data was collected, and the results of laboratory examinations were compared between the mild/moderate and severe COVID-19 groups. A ROC was calculated to compare the diagnostic performance of candidate indexes, and dynamic levels of hematological indexes were compared between the two groups. RESULT: 75 patients were enrolled, with a mean age of 46.6 ± 14 years, and 45 patients were male. All patients were classified into two groups: the mild/moderate group and the severe group. WBC, neutrophil to lymphocyte ratio (NLR), D-dimer, and fibrinogen levels of the severe group were significantly higher (P < 0.05) than the mild/moderate, and the lymphocyte was lower. The ROC test showed that the hematological parameters had a larger AUC than that of inflammatory factors. There was a significant difference in lymphocyte and fibrinogen levels between the two groups on day 1 (P < 0.05). However, NLR of the severe group was higher than the mild/moderate on days 1, 4 and 14 (P < 0.01), and so was D-dimer on days 1, 7 and 14 (P < 0.05). CONCLUSION: The common COVID-19 abnormal hematological indexes on admission included hyperfibrinogenemia, lymphopenia, the elevation of D-dimer, and leukopenia, which were significantly different between the mild/moderate and severe COVID-19 groups. Furthermore, the dynamic change of NLR and D-dimer level can distinguish severe COVID-19 cases from the mild/moderate.
|
Authors | Jianhong Fu, Jindan Kong, Wei Wang, Meiying Wu, Lin Yao, Zhaoyue Wang, Jun Jin, Depei Wu, Xin Yu |
Journal | Thrombosis research
(Thromb Res)
Vol. 192
Pg. 3-8
(08 2020)
ISSN: 1879-2472 [Electronic] United States |
PMID | 32407937
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2020 Elsevier Ltd. All rights reserved. |
Chemical References |
- Biomarkers
- Fibrin Fibrinogen Degradation Products
- fibrin fragment D
|
Topics |
- Adult
- Aged
- Betacoronavirus
(pathogenicity)
- Biomarkers
(blood)
- COVID-19
- COVID-19 Testing
- China
- Clinical Laboratory Techniques
- Coronavirus Infections
(blood, diagnosis, therapy, virology)
- Female
- Fibrin Fibrinogen Degradation Products
(analysis)
- Host-Pathogen Interactions
- Humans
- Lymphocyte Count
- Lymphocytes
- Male
- Middle Aged
- Neutrophils
- Pandemics
- Pneumonia, Viral
(blood, diagnosis, therapy, virology)
- Predictive Value of Tests
- Prognosis
- Reproducibility of Results
- Retrospective Studies
- SARS-CoV-2
- Severity of Illness Index
- Young Adult
|